> top > docs > PubMed:26201951 > annotations

PubMed:26201951 JSONTXT

Annnotations TAB JSON ListView MergeView

sentences

Id Subject Object Predicate Lexical cue
TextSentencer_T1 0-66 Sentence denotes A novel monoclonal antibody to a defined peptide epitope in MUC16.
TextSentencer_T2 67-150 Sentence denotes The MUC16 mucin is overexpressed and aberrantly glycosylated in ovarian carcinomas.
TextSentencer_T3 151-328 Sentence denotes Immunodetection of circulating MUC16 is one of the most used cancer biomarker assays, but existing antibodies to MUC16 fail to distinguish normal and aberrant cancer glycoforms.
TextSentencer_T4 329-480 Sentence denotes Although all antibodies react with the tandem-repeat region, their epitopes appear to be conformational dependent and not definable by a short peptide.
TextSentencer_T5 481-688 Sentence denotes Aberrant glycoforms of MUC16 may constitute promising targets for diagnostic and immunotherapeutic intervention, and it is important to develop well-defined immunogens for induction of potent MUC16 immunity.
TextSentencer_T6 689-876 Sentence denotes Here, we developed a MUC16 vaccine based on a 1.7TR (264 aa) expressed in Escherichia coli and in vitro enzymatically glycosylated to generate the aberrant cancer-associated glycoform Tn.
TextSentencer_T7 877-1027 Sentence denotes This vaccine elicited a potent serum IgG response in mice and we identified two major immunodominant linear peptide epitopes within the tandem repeat.
TextSentencer_T8 1028-1129 Sentence denotes We developed one monoclonal antibody, 5E11, reactive with a minimum epitope with the sequence FNTTER.
TextSentencer_T9 1130-1250 Sentence denotes This sequence contains potential N- and O-glycosylation sites and, interestingly, glycosylation blocked binding of 5E11.
TextSentencer_T10 1251-1432 Sentence denotes In immunochemistry of ovarian benign and cancer lesions, 5E11 showed similar reactivity as traditional MUC16 antibodies, suggesting that the epitope is not efficiently glycosylated.
TextSentencer_T11 1433-1506 Sentence denotes The study provides a vaccine design and immunodominant MUC16 TR epitopes.
T1 0-66 Sentence denotes A novel monoclonal antibody to a defined peptide epitope in MUC16.
T2 67-150 Sentence denotes The MUC16 mucin is overexpressed and aberrantly glycosylated in ovarian carcinomas.
T3 151-328 Sentence denotes Immunodetection of circulating MUC16 is one of the most used cancer biomarker assays, but existing antibodies to MUC16 fail to distinguish normal and aberrant cancer glycoforms.
T4 329-480 Sentence denotes Although all antibodies react with the tandem-repeat region, their epitopes appear to be conformational dependent and not definable by a short peptide.
T5 481-688 Sentence denotes Aberrant glycoforms of MUC16 may constitute promising targets for diagnostic and immunotherapeutic intervention, and it is important to develop well-defined immunogens for induction of potent MUC16 immunity.
T6 689-1027 Sentence denotes Here, we developed a MUC16 vaccine based on a 1.7TR (264 aa) expressed in Escherichia coli and in vitro enzymatically glycosylated to generate the aberrant cancer-associated glycoform Tn. This vaccine elicited a potent serum IgG response in mice and we identified two major immunodominant linear peptide epitopes within the tandem repeat.
T7 1028-1129 Sentence denotes We developed one monoclonal antibody, 5E11, reactive with a minimum epitope with the sequence FNTTER.
T8 1130-1250 Sentence denotes This sequence contains potential N- and O-glycosylation sites and, interestingly, glycosylation blocked binding of 5E11.
T9 1251-1432 Sentence denotes In immunochemistry of ovarian benign and cancer lesions, 5E11 showed similar reactivity as traditional MUC16 antibodies, suggesting that the epitope is not efficiently glycosylated.
T10 1433-1506 Sentence denotes The study provides a vaccine design and immunodominant MUC16 TR epitopes.
T1 0-66 Sentence denotes A novel monoclonal antibody to a defined peptide epitope in MUC16.
T2 67-150 Sentence denotes The MUC16 mucin is overexpressed and aberrantly glycosylated in ovarian carcinomas.
T3 151-328 Sentence denotes Immunodetection of circulating MUC16 is one of the most used cancer biomarker assays, but existing antibodies to MUC16 fail to distinguish normal and aberrant cancer glycoforms.
T4 329-480 Sentence denotes Although all antibodies react with the tandem-repeat region, their epitopes appear to be conformational dependent and not definable by a short peptide.
T5 481-688 Sentence denotes Aberrant glycoforms of MUC16 may constitute promising targets for diagnostic and immunotherapeutic intervention, and it is important to develop well-defined immunogens for induction of potent MUC16 immunity.
T6 689-876 Sentence denotes Here, we developed a MUC16 vaccine based on a 1.7TR (264 aa) expressed in Escherichia coli and in vitro enzymatically glycosylated to generate the aberrant cancer-associated glycoform Tn.
T7 877-1027 Sentence denotes This vaccine elicited a potent serum IgG response in mice and we identified two major immunodominant linear peptide epitopes within the tandem repeat.
T8 1028-1129 Sentence denotes We developed one monoclonal antibody, 5E11, reactive with a minimum epitope with the sequence FNTTER.
T9 1130-1250 Sentence denotes This sequence contains potential N- and O-glycosylation sites and, interestingly, glycosylation blocked binding of 5E11.
T10 1251-1432 Sentence denotes In immunochemistry of ovarian benign and cancer lesions, 5E11 showed similar reactivity as traditional MUC16 antibodies, suggesting that the epitope is not efficiently glycosylated.
T11 1433-1506 Sentence denotes The study provides a vaccine design and immunodominant MUC16 TR epitopes.

GlycoBiology-PACDB

Id Subject Object Predicate Lexical cue
_T1 763-779 http://acgg.asia/db/diseases/pacdb/lec?ids=LEC002,LEC056,LEC062,LEC069,LEC081,LEC111,LEC133,LEC171,LEC177,LEC187,LEC211,LEC242,LEC252,LEC258,LEC259,LEC260,LEC262,LEC369,LEC377,LEC422,LEC442,LEC448,LEC450,LEC451,LEC454,LEC472,LEC492,LEC620 denotes Escherichia coli
_T2 763-779 http://acgg.asia/db/diseases/pacdb/lec?ids=LEC157,LEC407 denotes Escherichia coli
_T3 763-779 http://acgg.asia/db/diseases/pacdb/lec?ids=LEC754 denotes Escherichia coli
_T4 763-779 http://acgg.asia/db/diseases/pacdb/lec?ids=LEC243,LEC640 denotes Escherichia coli
_T5 763-779 http://acgg.asia/db/diseases/pacdb/lec?ids=LEC295,LEC417 denotes Escherichia coli
_T6 763-779 http://acgg.asia/db/diseases/pacdb/lec?ids=LEC487 denotes Escherichia coli
_T7 763-779 http://acgg.asia/db/diseases/pacdb/lec?ids=LEC244,LEC256,LEC354 denotes Escherichia coli
_T8 763-779 http://acgg.asia/db/diseases/pacdb/lec?ids=LEC054,LEC058,LEC073,LEC082,LEC091,LEC103,LEC109,LEC110,LEC123,LEC158,LEC179,LEC198,LEC205,LEC222,LEC223,LEC224,LEC225,LEC232,LEC298,LEC357,LEC378,LEC383,LEC388,LEC389,LEC397,LEC401,LEC410,LEC452 denotes Escherichia coli
_T9 763-779 http://acgg.asia/db/diseases/pacdb/lec?ids=LEC636 denotes Escherichia coli

GlycoBiology-FMA

Id Subject Object Predicate Lexical cue
_T1 19-27 FMAID:167180 denotes antibody
_T2 250-260 FMAID:167180 denotes antibodies
_T3 342-352 FMAID:167180 denotes antibodies
_T4 908-913 FMAID:167330 denotes serum
_T5 914-917 FMAID:167179 denotes IgG
_T6 1056-1064 FMAID:167180 denotes antibody
_T7 1360-1370 FMAID:167180 denotes antibodies

uniprot-human

Id Subject Object Predicate Lexical cue
T1 60-65 http://www.uniprot.org/uniprot/Q8WXI7 denotes MUC16
T2 71-76 http://www.uniprot.org/uniprot/Q8WXI7 denotes MUC16
T3 182-187 http://www.uniprot.org/uniprot/Q8WXI7 denotes MUC16
T4 264-269 http://www.uniprot.org/uniprot/Q8WXI7 denotes MUC16
T5 504-509 http://www.uniprot.org/uniprot/Q8WXI7 denotes MUC16
T6 673-678 http://www.uniprot.org/uniprot/Q8WXI7 denotes MUC16
T7 710-715 http://www.uniprot.org/uniprot/Q8WXI7 denotes MUC16
T8 1354-1359 http://www.uniprot.org/uniprot/Q8WXI7 denotes MUC16
T9 1488-1493 http://www.uniprot.org/uniprot/Q8WXI7 denotes MUC16
T10 1494-1496 http://www.uniprot.org/uniprot/Q6YNQ1 denotes TR
T11 1494-1496 http://www.uniprot.org/uniprot/P02786 denotes TR
T12 1494-1496 http://www.uniprot.org/uniprot/P25116 denotes TR

uniprot-mouse

Id Subject Object Predicate Lexical cue
T1 1494-1496 http://www.uniprot.org/uniprot/Q9JMH6 denotes TR
T2 1494-1496 http://www.uniprot.org/uniprot/Q62351 denotes TR

GlycoBiology-NCBITAXON

Id Subject Object Predicate Lexical cue
T1 8-18 http://purl.bioontology.org/ontology/NCBITAXON/608684 denotes monoclonal
T2 139-149 http://purl.bioontology.org/ontology/NCBITAXON/166034 denotes carcinomas
T3 212-218 http://purl.bioontology.org/ontology/NCBITAXON/6754 denotes cancer
T4 310-316 http://purl.bioontology.org/ontology/NCBITAXON/6754 denotes cancer
T5 481-489 http://purl.bioontology.org/ontology/NCBITAXON/317910 denotes Aberrant
T6 746-748 http://purl.bioontology.org/ontology/NCBITAXON/152839 denotes aa
T7 763-774 http://purl.bioontology.org/ontology/NCBITAXON/561 denotes Escherichia
T8 845-851 http://purl.bioontology.org/ontology/NCBITAXON/6754 denotes cancer
T9 1045-1055 http://purl.bioontology.org/ontology/NCBITAXON/608684 denotes monoclonal
T10 1292-1298 http://purl.bioontology.org/ontology/NCBITAXON/6754 denotes cancer

GO-BP

Id Subject Object Predicate Lexical cue
T1 115-127 http://purl.obolibrary.org/obo/GO_0070085 denotes glycosylated
T2 807-819 http://purl.obolibrary.org/obo/GO_0070085 denotes glycosylated
T3 1172-1185 http://purl.obolibrary.org/obo/GO_0070085 denotes glycosylation
T4 1212-1225 http://purl.obolibrary.org/obo/GO_0070085 denotes glycosylation
T5 617-624 http://purl.obolibrary.org/obo/GO_0032502 denotes develop
T6 698-707 http://purl.obolibrary.org/obo/GO_0032502 denotes developed
T7 1031-1040 http://purl.obolibrary.org/obo/GO_0032502 denotes developed

GO-MF

Id Subject Object Predicate Lexical cue
T1 19-27 http://purl.obolibrary.org/obo/GO_0003823 denotes antibody
T2 250-260 http://purl.obolibrary.org/obo/GO_0003823 denotes antibodies
T3 342-352 http://purl.obolibrary.org/obo/GO_0003823 denotes antibodies
T4 1360-1370 http://purl.obolibrary.org/obo/GO_0003823 denotes antibodies
T5 1234-1241 http://purl.obolibrary.org/obo/GO_0070026 denotes binding
T6 1234-1241 http://purl.obolibrary.org/obo/GO_0003680 denotes binding
T7 1234-1241 http://purl.obolibrary.org/obo/GO_0017091 denotes binding
T8 1234-1241 http://purl.obolibrary.org/obo/GO_0005488 denotes binding

UBERON-AE

Id Subject Object Predicate Lexical cue
T1 908-913 http://purl.obolibrary.org/obo/UBERON_0001977 denotes serum

performance-test

Id Subject Object Predicate Lexical cue
PD-UBERON-AE-B_T1 908-913 http://purl.obolibrary.org/obo/UBERON_0001977 denotes serum

GlyTouCan-IUPAC

Id Subject Object Predicate Lexical cue
GlycanIUPAC_T1 338-341 "http://rdf.glycoinfo.org/glycan/G41652MJ" denotes all
GlycanIUPAC_T2 338-341 "http://rdf.glycoinfo.org/glycan/G20761YC" denotes all
GlycanIUPAC_T3 338-341 "http://rdf.glycoinfo.org/glycan/G19807HM" denotes all
GlycanIUPAC_T4 338-341 "http://rdf.glycoinfo.org/glycan/G20351TE" denotes all
GlycanIUPAC_T5 338-341 "http://rdf.glycoinfo.org/glycan/G71957MR" denotes all
GlycanIUPAC_T6 338-341 "http://rdf.glycoinfo.org/glycan/G59040AE" denotes all
GlycanIUPAC_T7 338-341 "http://rdf.glycoinfo.org/glycan/G14987PW" denotes all
GlycanIUPAC_T8 338-341 "http://rdf.glycoinfo.org/glycan/G95064PC" denotes all
GlycanIUPAC_T9 338-341 "http://rdf.glycoinfo.org/glycan/G39143AQ" denotes all
GlycanIUPAC_T10 338-341 "http://rdf.glycoinfo.org/glycan/G65149OO" denotes all
GlycanIUPAC_T11 338-341 "http://rdf.glycoinfo.org/glycan/G02766SY" denotes all
GlycanIUPAC_T12 338-341 "http://rdf.glycoinfo.org/glycan/G26019KJ" denotes all
GlycanIUPAC_T13 338-341 "http://rdf.glycoinfo.org/glycan/G36429CZ" denotes all
GlycanIUPAC_T14 338-341 "http://rdf.glycoinfo.org/glycan/G89633TP" denotes all
GlycanIUPAC_T15 338-341 "http://rdf.glycoinfo.org/glycan/G28494FO" denotes all
GlycanIUPAC_T16 338-341 "http://rdf.glycoinfo.org/glycan/G06219CP" denotes all
GlycanIUPAC_T17 338-341 "http://rdf.glycoinfo.org/glycan/G44237SM" denotes all
GlycanIUPAC_T18 338-341 "http://rdf.glycoinfo.org/glycan/G57948RL" denotes all
GlycanIUPAC_T19 338-341 "http://rdf.glycoinfo.org/glycan/G64016DN" denotes all
GlycanIUPAC_T20 338-341 "http://rdf.glycoinfo.org/glycan/G14536PC" denotes all
GlycanIUPAC_T21 338-341 "http://rdf.glycoinfo.org/glycan/G14356FW" denotes all
GlycanIUPAC_T22 338-341 "http://rdf.glycoinfo.org/glycan/G34565UO" denotes all
GlycanIUPAC_T23 338-341 "http://rdf.glycoinfo.org/glycan/G67124MW" denotes all
GlycanIUPAC_T24 338-341 "http://rdf.glycoinfo.org/glycan/G71457ZU" denotes all
GlycanIUPAC_T25 338-341 "http://rdf.glycoinfo.org/glycan/G55228VZ" denotes all
GlycanIUPAC_T26 338-341 "http://rdf.glycoinfo.org/glycan/G31034MJ" denotes all
GlycanIUPAC_T27 338-341 "http://rdf.glycoinfo.org/glycan/G25776IP" denotes all
GlycanIUPAC_T28 338-341 "http://rdf.glycoinfo.org/glycan/G64442BV" denotes all
GlycanIUPAC_T29 338-341 "http://rdf.glycoinfo.org/glycan/G57018LE" denotes all
GlycanIUPAC_T30 338-341 "http://rdf.glycoinfo.org/glycan/G61761GX" denotes all
GlycanIUPAC_T31 338-341 "http://rdf.glycoinfo.org/glycan/G76318UX" denotes all
GlycanIUPAC_T32 338-341 "http://rdf.glycoinfo.org/glycan/G61906ER" denotes all
GlycanIUPAC_T33 338-341 "http://rdf.glycoinfo.org/glycan/G68723GR" denotes all
GlycanIUPAC_T34 338-341 "http://rdf.glycoinfo.org/glycan/G19540LE" denotes all
GlycanIUPAC_T35 338-341 "http://rdf.glycoinfo.org/glycan/G74944PO" denotes all
GlycanIUPAC_T36 338-341 "http://rdf.glycoinfo.org/glycan/G89489ZJ" denotes all
GlycanIUPAC_T37 338-341 "http://rdf.glycoinfo.org/glycan/G04434YU" denotes all
GlycanIUPAC_T38 338-341 "http://rdf.glycoinfo.org/glycan/G21450PB" denotes all
GlycanIUPAC_T39 338-341 "http://rdf.glycoinfo.org/glycan/G93629QY" denotes all
GlycanIUPAC_T40 338-341 "http://rdf.glycoinfo.org/glycan/G02603TR" denotes all
GlycanIUPAC_T41 338-341 "http://rdf.glycoinfo.org/glycan/G40280JP" denotes all
GlycanIUPAC_T42 338-341 "http://rdf.glycoinfo.org/glycan/G95259IC" denotes all
GlycanIUPAC_T43 338-341 "http://rdf.glycoinfo.org/glycan/G26900FE" denotes all
GlycanIUPAC_T44 338-341 "http://rdf.glycoinfo.org/glycan/G21346KK" denotes all
GlycanIUPAC_T45 338-341 "http://rdf.glycoinfo.org/glycan/G62509FF" denotes all
GlycanIUPAC_T46 338-341 "http://rdf.glycoinfo.org/glycan/G83932AK" denotes all
GlycanIUPAC_T47 338-341 "http://rdf.glycoinfo.org/glycan/G96978IB" denotes all
GlycanIUPAC_T48 338-341 "http://rdf.glycoinfo.org/glycan/G34275DN" denotes all
GlycanIUPAC_T49 338-341 "http://rdf.glycoinfo.org/glycan/G07071JF" denotes all
GlycanIUPAC_T50 338-341 "http://rdf.glycoinfo.org/glycan/G80639QD" denotes all
GlycanIUPAC_T51 338-341 "http://rdf.glycoinfo.org/glycan/G99460PJ" denotes all
GlycanIUPAC_T52 338-341 "http://rdf.glycoinfo.org/glycan/G22024BZ" denotes all
GlycanIUPAC_T53 338-341 "http://rdf.glycoinfo.org/glycan/G74097ZY" denotes all
GlycanIUPAC_T54 338-341 "http://rdf.glycoinfo.org/glycan/G84439YP" denotes all
GlycanIUPAC_T55 338-341 "http://rdf.glycoinfo.org/glycan/G52207WQ" denotes all
GlycanIUPAC_T56 338-341 "http://rdf.glycoinfo.org/glycan/G90695MS" denotes all
GlycanIUPAC_T57 338-341 "http://rdf.glycoinfo.org/glycan/G50398QX" denotes all
GlycanIUPAC_T58 338-341 "http://rdf.glycoinfo.org/glycan/G12166ZT" denotes all
GlycanIUPAC_T59 338-341 "http://rdf.glycoinfo.org/glycan/G48368BR" denotes all
GlycanIUPAC_T60 338-341 "http://rdf.glycoinfo.org/glycan/G57407RW" denotes all
GlycanIUPAC_T61 338-341 "http://rdf.glycoinfo.org/glycan/G00386TY" denotes all
GlycanIUPAC_T62 338-341 "http://rdf.glycoinfo.org/glycan/G18723JK" denotes all
GlycanIUPAC_T63 338-341 "http://rdf.glycoinfo.org/glycan/G93757OR" denotes all
GlycanIUPAC_T64 338-341 "http://rdf.glycoinfo.org/glycan/G29006SI" denotes all
GlycanIUPAC_T65 338-341 "http://rdf.glycoinfo.org/glycan/G03099OQ" denotes all
GlycanIUPAC_T66 338-341 "http://rdf.glycoinfo.org/glycan/G53739OW" denotes all
GlycanIUPAC_T67 338-341 "http://rdf.glycoinfo.org/glycan/G70440ZO" denotes all
GlycanIUPAC_T68 338-341 "http://rdf.glycoinfo.org/glycan/G29951RR" denotes all
GlycanIUPAC_T69 338-341 "http://rdf.glycoinfo.org/glycan/G58402TI" denotes all
GlycanIUPAC_T70 338-341 "http://rdf.glycoinfo.org/glycan/G39875TP" denotes all
GlycanIUPAC_T71 338-341 "http://rdf.glycoinfo.org/glycan/G83439QV" denotes all
GlycanIUPAC_T72 338-341 "http://rdf.glycoinfo.org/glycan/G41762RC" denotes all
GlycanIUPAC_T73 338-341 "http://rdf.glycoinfo.org/glycan/G91604UI" denotes all
GlycanIUPAC_T74 338-341 "http://rdf.glycoinfo.org/glycan/G88447WE" denotes all
GlycanIUPAC_T75 338-341 "http://rdf.glycoinfo.org/glycan/G93634BS" denotes all
GlycanIUPAC_T76 338-341 "http://rdf.glycoinfo.org/glycan/G02587BH" denotes all
GlycanIUPAC_T77 338-341 "http://rdf.glycoinfo.org/glycan/G43511MX" denotes all
GlycanIUPAC_T78 338-341 "http://rdf.glycoinfo.org/glycan/G64958DH" denotes all
GlycanIUPAC_T79 338-341 "http://rdf.glycoinfo.org/glycan/G30384TR" denotes all
GlycanIUPAC_T80 338-341 "http://rdf.glycoinfo.org/glycan/G15624EX" denotes all
GlycanIUPAC_T81 338-341 "http://rdf.glycoinfo.org/glycan/G22706ST" denotes all
GlycanIUPAC_T82 338-341 "http://rdf.glycoinfo.org/glycan/G57408PI" denotes all
GlycanIUPAC_T83 338-341 "http://rdf.glycoinfo.org/glycan/G86403XX" denotes all
GlycanIUPAC_T84 338-341 "http://rdf.glycoinfo.org/glycan/G78043YB" denotes all
GlycanIUPAC_T85 338-341 "http://rdf.glycoinfo.org/glycan/G18952JK" denotes all
GlycanIUPAC_T86 338-341 "http://rdf.glycoinfo.org/glycan/G49020ND" denotes all
GlycanIUPAC_T87 338-341 "http://rdf.glycoinfo.org/glycan/G63590YW" denotes all
GlycanIUPAC_T88 338-341 "http://rdf.glycoinfo.org/glycan/G22793KS" denotes all
GlycanIUPAC_T89 338-341 "http://rdf.glycoinfo.org/glycan/G64134SS" denotes all
GlycanIUPAC_T90 338-341 "http://rdf.glycoinfo.org/glycan/G17338HY" denotes all
GlycanIUPAC_T91 338-341 "http://rdf.glycoinfo.org/glycan/G99745XF" denotes all
GlycanIUPAC_T92 338-341 "http://rdf.glycoinfo.org/glycan/G27782HN" denotes all
GlycanIUPAC_T93 338-341 "http://rdf.glycoinfo.org/glycan/G57496DC" denotes all
GlycanIUPAC_T94 338-341 "http://rdf.glycoinfo.org/glycan/G93169WB" denotes all
GlycanIUPAC_T95 338-341 "http://rdf.glycoinfo.org/glycan/G05518TD" denotes all
GlycanIUPAC_T96 338-341 "http://rdf.glycoinfo.org/glycan/G62603DN" denotes all
GlycanIUPAC_T97 338-341 "http://rdf.glycoinfo.org/glycan/G59574FS" denotes all
GlycanIUPAC_T98 338-341 "http://rdf.glycoinfo.org/glycan/G47567WC" denotes all

Lectin

Id Subject Object Predicate Lexical cue
Lectin_T1 873-875 https://acgg.asia/db/lfdb/LfDB0021 denotes Tn

mondo_disease

Id Subject Object Predicate Lexical cue mondo_id
T1 131-149 Disease denotes ovarian carcinomas http://purl.obolibrary.org/obo/MONDO_0005140
T2 212-218 Disease denotes cancer http://purl.obolibrary.org/obo/MONDO_0004992
T3 310-316 Disease denotes cancer http://purl.obolibrary.org/obo/MONDO_0004992
T4 845-851 Disease denotes cancer http://purl.obolibrary.org/obo/MONDO_0004992
T5 1292-1298 Disease denotes cancer http://purl.obolibrary.org/obo/MONDO_0004992

NCBITAXON

Id Subject Object Predicate Lexical cue db_id
T1 763-779 OrganismTaxon denotes Escherichia coli 562
T2 930-934 OrganismTaxon denotes mice 10088

HP-phenotype

Id Subject Object Predicate Lexical cue hp_id
T1 131-149 Phenotype denotes ovarian carcinomas HP:0025318
T2 212-218 Phenotype denotes cancer HP:0002664
T3 310-316 Phenotype denotes cancer HP:0002664
T4 845-851 Phenotype denotes cancer HP:0002664
T5 1292-1298 Phenotype denotes cancer HP:0002664